Background

Sophia completed a Master of Public Health at Lund University in Sweden in 2017. For her thesis project she joined Burnet Institute and conducted a qualitative study of risk perceptions and attitudes towards hepatitis C reinfection among HIV-diagnosed gay and bisexual men recently cured from hepatitis C.

She now works at Burnet Institute as a research assistant across multiple projects. Sophia has a particular interest in qualitative research seeking to understand and address barriers to wellbeing among disadvantaged and high-risk populations, including prisoners and ex-prisoners, people who use drugs, gay and bisexual men, and young people.

Qualifications

• 2015: Bachelor of Arts in Peace and Conflict Studies, Malmö University, Sweden
• 2017: Master of Science (Public Health), Lund University, Sweden

Projects (2)

Current (1)

• 

  co-EC Study: Eliminating hepatitis C/HIV coinfection

Publications (8)

2020 (5)

• A global investment framework for the elimination of hepatitis B.
  Howell J, Pedrana A, Schroeder SE, Scott N, Aufegger L, Atun R, Baptista-Leite R, Hirnschal G, Hoen E', Hutchinson SJ, Lazarus JV, Olufunmilayo L, Peck R, Sharma M, Sohn AH, Thompson A, Thursz M, Wilson D, Hellard M
  J Hepatol. 2020 Sep; Epub ahead of print
• Authors' response to Letter to the Editor: "Colombian experience in the management of hepatitis C".
  Schroeder S, Pedrana A, Scott N, Hellard M
  Liver Int. 2020 Sep; Epub ahead of print
• Global hepatitis C elimination: an investment framework.
  Pedrana A, Howell J, Scott N, Schroeder S, Kuschel C, Lazarus JV, Atun R, Baptista-Leite R, 't Hoen E, Hutchinson SJ, Aufegger L, Peck R, Sohn AH, Swan T, Thursz M, Lesi O, Sharma M, Thwaites J, Wilson DP, Hellard M
  Lancet Gastroenterol Hepatol. 2020 Jul; 5(10):927-939
• A model of the economic benefits of global hepatitis C elimination: an investment case.
  Scott N, Kuschel C, Pedrana A, Schroeder S, Howell J, Thompson A, Wilson DP, Hellard M
  Lancet Gastroenterol Hepatol. 2020 Jul; 5(10):940-947
• The Elimination of Hepatitis C as a Public Health Threat.
  Hellard M, Schroeder SE, Pedrana A, Doyle J, Aitken C
  Cold Spring Harb Perspect Med. 2020 Jan; 10(4):a036939

2019 (2)

• Innovative strategies for the elimination of viral hepatitis at a national level: a country case series.
  Schroeder ES, Pedrana A, Scott N, Wilson D, Kuschel C, Aufegger L, Atun R, Baptista-Leite R, Butsashvili M, El-Sayed M, Getahun A, Hamid S, Hammad R, 't Hoen E, Hutchinson SJ, Lazarus JV, Lesi O, Li W, Mohamed RB, Olafsson S, Peck R, Sohn AH, Sonderup M, Spearman CW, Swan T, Thursz M, Walker T, Hellard M, Howell J
  Liver Int. 2019 Aug; Epub ahead of print
• Hepatitis C risk perceptions and attitudes towards reinfection among HIV-diagnosed gay and bisexual men in Melbourne, Australia.
  Schroeder SE, Higgs P, Winter R, Brown G, Pedrana A, Hellard M, Doyle J, Stoové M
  J Int AIDS Soc. 2019 May; 22(5):e25288

2018 (1)

• Effects of Pre-exposure Prophylaxis for the Prevention of HIV Infection on Sexual Risk Behavior in Men Who Have Sex with Men: A Systematic Review and Meta-analysis.
  Traeger MW, Schroeder SE, Wright EJ, Hellard ME, Cornelisse VJ, Doyle JS, Stoové MA
  Clin Infect Dis. 2018 Mar; 67(5):676-686

News Articles (2)

2019 (1)

• Burnet Travel Awards

2018 (1)

• WISH for hepatitis elimination is achievable